Study of Turning Point Therapeutics LM-302 in Patients With Advance Solid Tumors

Clinical trial NCT05001516 · COMPLETED

Trial details

NCT number: NCT05001516
Sponsor: Turning Point Therapeutics, Inc.
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Advanced Solid Tumor

Start date: 2021-12-29
Primary completion: 2024-01-04
Enrollment: 17

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.